Somatropin is used for treating deficiency of growth hormone in children as well as adults. Moreover, it is also used for the treatment of Prader-Willi Syndrome, Turner Syndrome, Chronic kidney diseases and others. With the increase in cases of growth hormone deficiency, the market for somatropin is likely to witness substantial growth.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/4062
Rise in number of growth hormone deficiency cases is anticipated to propel growth of the global somatropin market over the forecast period. For instance, in July 2019, the International Journal of Molecular Sciences published a study, according to which the prevalence rate of severe growth hormone deficiency in one month after a traumatic brain injury is nearly 2 to 30% and the condition found in chronic stage of traumatic brain injury has 10 to 63.6% prevalence rate.
Moreover, players in the market and research institutes are focusing on collaborative clinical trials for development of products from somatropin and this in turn is anticipated to boost growth of the global somatropin market over the forecast period. For instance, Nemours Children’s Clinic started an observational study with Novo Nordisk A/S in July 2019 for evaluating the useful effects of the recombinant growth hormone in children with short prepuberty having growth hormone deficiency or idiopathic short stature.
Impact of COVID-19:
The outbreak of coronavirus in China spread across more than 200 countries all over the world. It adversely affected the global economies as the production and demand of products were disrupted and distribution channels along with various firms and financial markets were disrupted after the virus outbreak. Various market activities such as manufacturing, in countries such as China, the U.S. and India were disrupted as the many countries imposed lockdown regulations. Moreover the pandemic also affected transportation of drugs in several countries.
- The global somatropin market is expected to show a CAGR of 7.9% over the forecast period due to rise in number of cases of chronic renal insufficiency or chronic kidney disorder. For instance, as per the Quality and Outcomes Framework, during 2017-18, the cases of chronic kidney disorders of stage 3-5 was nearly 4.1 every 100 in England.
- Increasing approvals from regulatory authorities is expected to propel growth of the Solvent Segment among Dosage Form in the global somatropin market over the forecast period. For instance, Ascendis Pharma A/S received the Orphan Designation in October 2019 for its TransCon Growth Hormone (hGH) by the European Commission
- Rise in cases of growth hormone deficiency is likely to fuel growth of the segment Growth Hormone Deficiency (GHD) among Applications in the global somatropin market over the forecast period. For instance, in March 2019, the Journal of Pediatric Endocrinology and Metabolism published an article according to which, in 2016 the prevalence rate of GHD in children was nearly 1 in every 4000 in the U.K.
Major players functioning in the global somatropin market include Ferring Pharmaceuticals, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., F. Hoffmann-La Roche, Eli Lilly and Company, Merck KGaA, GeneScience Pharmaceuticals, LG Life Sciences, Sandoz International, and Ipsen Inc.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4062
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Somatropin Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Somatropin Industry Impact
Chapter 2 Global Somatropin Competition by Types, Applications, and Top Regions and Countries
2.1 Global Somatropin (Volume and Value) by Type
2.3 Global Somatropin (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Somatropin Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Somatropin Market Analysis
Chapter 6 East Asia Somatropin Market Analysis
Chapter 7 Europe Somatropin Market Analysis
Chapter 8 South Asia Somatropin Market Analysis
Chapter 9 Southeast Asia Somatropin Market Analysis
Chapter 10 Middle East Somatropin Market Analysis
Chapter 11 Africa Somatropin Market Analysis
Chapter 12 Oceania Somatropin Market Analysis
Chapter 13 South America Somatropin Market Analysis
Chapter 14 Company Profiles and Key Figures in Somatropin Business
Chapter 15 Global Somatropin Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4062
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027